Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction

American Journal of Cardiology

Volumn 79, Issue 5, 1997, Pages 587-589

  Cucherat, Michel ^a,b   Boissel, Jean Pierre ^a   Leizorovicz, Alain ^a  

^a Hopital Cardiologigue   (France)

^b Service de Pharmacologie Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TIMOLOL;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ACEBUTOLOL; ACTUARIAL ANALYSIS; ADRENERGIC BETA-ANTAGONISTS; CAUSE OF DEATH; FOLLOW-UP STUDIES; FRANCE; HUMANS; LONGITUDINAL STUDIES; MYOCARDIAL INFARCTION; PLACEBOS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE;

EID: 0030896503     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00820-X     Document Type: Article

References (7)

1. Yusuf S, Peto R, Lewis J, Collins R. Sleight T. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progr Cardiovasc Dis 1985;27:335-371.
2. Beta-Block Pooling Project Research Group. The Beta-Blocker Pooling Project (BBPP) research group. Subgroup findings form randomized trials in post infarction patieints. Eur Heart J 1988;9:8-16.
3. Pedersen TR, for the Norwegian Multicenter Study Group. Six year follow-up of the Norwegian Multicenter Study on Timolol after acute myocardial infarction. N Engl J Med 1985;313:1055-1058.
4. Taylor SH, Silke B, Ebbutt A, Sutton GC, Prout BJ, Burley DM. A long-term prevention study with oxprenolol in coronary heart disease. N Engl J Med 1982;307:1293-1301.
5. Boissel JP, Leizorovicz A, Pielet H, Peyrierux JC, for the APSI Invesigators. Secondary prevention after high risk acute myocardial infarction with low-dose acebutolol. Am J Cardiol 1990;66:251-260.
6. Boisel JP, Leizorovicz A, Picolet H, Ducruet T, and the APSI Investigators. Efficacy of acebutolol after acute myocardial infarction (The APSI trial). Am J Cardiol 1990;66:24C-31C.
7. European Infarction Study Group. European Infarction Study (EIS): a secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality. Eur Heart J 1984;5:189-202.